Extended resections for hilar cholangiocarcinoma

Annals of Surgery

Volumn 230, Issue 6, 1999, Pages 808-819

  Neuhaus, Peter ^a   Jonas, Sven ^a   Bechstein, Wolf O ^a   Lohmann, Rüdiger ^a   Radke, Cornelia ^a   Kling, Norbert ^a   Wex, Cora ^a   Lobeck, Hartmut ^a   Hintze, Rainer ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BILE DUCT CARCINOMA; CONFERENCE PAPER; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; SURVIVAL RATE;

AGED; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PORTAL VEIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0033511444     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199912000-00010     Document Type: Conference Paper

References (33)

1. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31-38.
2. Blumgart LH, Benjamin IS. Liver resection for bile duct cancer. Surg Clin North Am 1989; 69:323-337.
3. Bengmark S, Blumgart LH, Launois B. Liver resection in high bile duct tumors. In: Bengmark S, Blumgart LH, eds. Liver surgery. Edinburgh: Churchill Livingstone; 1986:81-87.
4. Mittal B, Deutsch M, Iwatsuki S. Primary cancers of the extrahepatic biliary passages. Int J Radiat Oncol Biol Phys 1985; 11:849-855.
5. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996; 224:628-638.
6. Su CH, Tsay SH, Wu CC, et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223:384-394.
7. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 1982; 6:3-9.
8. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107:521-527.
9. Vogl TJ, Balzer JO, Dette K, et al. Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization. Radiology 1998; 208:217-222.
10. Curley SA, Levin B, Rich TA. Management of specific malignancies: liver and bile ducts. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical oncology. New York: Churchill Livingstone; 1995:1305-1372.
11. Yokoyama I, Carr B, Saitsu H, et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991; 68:2095-2100.
12. Beckurts KTE, Hölscher AH, Bauer TH, Siewert JR. Malignant tumors of the hepatic bifurcation: results of surgical therapy and prognostic factors. Chirurg 1997; 68:378-384.
13. Neuhaus P, Blumhardt G. Extended bile duct resection: a new oncological approach to the treatment of central bile duct carcinomas? Description of method and early results. Langenbecks Arch Chir 1994; 379:123-128.
14. Jonas S, Kling N, Bechstein WO, et al. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled prospective randomized trial. Clin Transpl 1995; 9:406-414.
15. Beazley RM, Hadjis N, Benjamin IS. Clinicopathological subjects of high bile duct cancer: experience with resection and bypass surgical treatments. Ann Surg 1984; 199:623-636.
16. Jonas S, Bechstein WO, Lemmens HP, et al. Conversion to tacrolimus after liver transplantation. Transpl Int 1996; 9:23-31.
17. Colombari R, Tsui WMS. Biliary tumors of the liver. Semin Liv Dis 1995; 15:402-413.
18. Sugihara S, Kojiro M. Pathology of cholangiocarcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the liver. Tokyo: Springer Verlag; 1987:236-301.
19. Bhuiya MR, Nimura Y, Kamiya J, et al. Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 1992; 215:344-349.
20. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983; 139:217-238.
21. Mizumoto R, Kawarada Y, Suzuki H. Surgical treatment of hilar carcinoma of the bile duct. Surg Gynecol Obstet 1986; 162:153-158.
22. Heald RJ, Ryall R. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1:1479-1482.
23. Heald RJ. The "holy plane" of rectal surgery. J R Soc Med 1988; 81:503-508.
24. Verbeek PCM, van Leeuwen DJ, de Wit LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112:866-871.
25. Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991; 161:57-63.
26. Gerhards MF, van Gulik TM, Bosma A, et al. Long-term survival after resection of proximal bile duct carcinoma (Klatskin tumors). World J Surg 1999; 23:91-96.
27. Verbeek PCM, van der Heyde MN, Ramsoekh T, Bosma A. Clinical significance of implantation metastases after surgical treatment of cholangiocarcinoma. Semin Liv Dis 1990; 10:142-144.
28. Alessiani M, Tzakis A, Todo S, et al. Assessment of five-year experience with abdominal cluster transplantation. J Am Coll Surg 1995; 180:1-9.
29. Starzl TE, Todo S, Tzakis A, et al. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989; 210:374-386.
30. Nimura Y, Hayakawa N, Kamiya J, et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology 1991; 38:170-175.
31. Reding R, Buard JL, Lebeau G, Launois B. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Association survey. Ann Surg 1991; 219:236-241.
32. Takada T, Yasuda H. Value of preoperative biliary drainage prior to bile duct cancer surgery: results of a retrospective review. Asian J Surg 1996; 19:84-87.
33. Hatfield ARW, Tobias R, Terblanche J, et al. Preoperative external biliary drainage in obstructive jaundice: a prospective controlled clinical trial. Lancet 1982; 2:896-899.